Global Human Organs-on-Chips Market
完整報告名稱與涵蓋範圍
Global Human Organs-on-Chips Market 2026 by Company, Regions, Type and Application, Forecast to 2032
報告摘要
According to our (Global Info Research) latest study, the global Human Organs-on-Chips market size was valued at US$ 230 million in 2025 and is forecast to a readjusted size of US$ 1452 million by 2032 with a CAGR of 30.5% during review period.
An Human Organs-on-Chip is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels. Usually Human Organs-on-Chip mainly refers to organ chips.
The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumors), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).
In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.The industry's gross profit margin is approximately 40–50%.
Key market drivers include the following:
Demand for improved drug R&D efficiency drives technology adoption
"Organ-on-a-chip" technology is an in vitro research platform that integrates microfluidics, biomaterials, cell culture, and tissue engineering to simulate the structures, cellular interactions, and dynamic physiological environments of human organs within a miniature device. Traditional 2D cell models struggle to replicate the complex responses of human tissues, while animal experiments face limitations regarding species differences, costs, timelines, and ethical concerns. Pharmaceutical companies need to identify the toxicity, absorption, metabolism, and efficacy of drug candidates at an earlier stage to reduce the risk of clinical trial failure. Organ-on-a-chip systems can simulate blood flow, mechanical stretching, fluid shear stress, and multicellular co-culture environments, providing experimental conditions that more closely mimic the human body for studying organs such as the liver, lungs, intestines, kidneys, and heart, as well as the blood-brain barrier; consequently, they are increasingly being incorporated into drug screening and safety assessment workflows.
Precision medicine and disease modeling expand application boundaries
Biopharmaceutical R&D is shifting from standardized drug development toward targeted therapies, cell therapies, gene therapies, and personalized medicine, placing higher demands on the disease relevance of models and their ability to simulate patient-specific differences. Organ-on-a-chip platforms can utilize patient-derived cells, induced pluripotent stem cells (iPSCs), or tumor tissues to construct specific disease models, enabling the study of disease progression, drug sensitivity, and individual responses to treatment. Multi-organ-on-a-chip systems can also connect various tissue modules to simulate the processes of drug absorption, distribution, metabolism, and toxicity within the human body. As technologies related to cell sources, culture media, sensors, and imaging analysis mature, organ-on-a-chip technology will evolve from simple single-organ functional validation to the study of complex disease mechanisms and the evaluation of combination therapies.
The trend toward replacing animal testing and the establishment of standardization systems are accelerating commercialization.
The global life sciences industry continues to drive efforts to reduce, refine, and replace animal testing, with regulatory bodies, research institutions, and pharmaceutical companies increasingly accepting novel *in vitro* models. If organ-on-a-chip systems can yield stable, reproducible, and verifiable results, they hold the potential for use in specific drug toxicology tests, chemical safety assessments, and medical product research. Meanwhile, advancements in automated culture systems, standardized chip interfaces, real-time sensing, AI-driven image analysis, and high-throughput equipment are lowering operational barriers and enhancing experimental consistency. Future market growth will hinge on cross-laboratory validation, evaluation standards, regulatory approval, and scalable manufacturing capabilities; platforms that are compatible with existing laboratory equipment and feature comprehensive data analysis software and standard operating procedures are the most likely to achieve successful commercialization.
Report Scope
This report is a detailed and comprehensive analysis for global Human Organs-on-Chips market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Organs-on-Chips market size and forecasts, in consumption value ($ Million), 2021-2032
Global Human Organs-on-Chips market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Human Organs-on-Chips market size and forecasts, by Type and by End User, in consumption value ($ Million), 2021-2032
Global Human Organs-on-Chips market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Organs-on-Chips
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Organs-on-Chips market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Emulate, Mimetas, TissUse, Valo Health, CN Bio Innovations, Hesperos, Draper Laboratory, Nortis, Micronit Microtechnologies B.V., Kirkstall, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Human Organs-on-Chips market is split by Type and by End User. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by End User. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs
Market segment by Technology
Cell Monolayer Chip
Scaffold or Hydrogel 3D Chip
Spheroid Chip
Other
Market segment by Integration Level
Single-Organ Chip
Multi-Tissue Organ Chip
Others
Market segment by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
Market segment by players, this report covers
Emulate
Mimetas
TissUse
Valo Health
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Xona Microfluidics
SynVivo
Beijing Daxiang Biotech
AVATARGET
Suzhou Jiyan Biopharmaceutical
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Human Organs-on-Chips product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Human Organs-on-Chips, with revenue, gross margin, and global market share of Human Organs-on-Chips from 2021 to 2026.
Chapter 3, the Human Organs-on-Chips competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by End User, with consumption value and growth rate by Type, by End User, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Human Organs-on-Chips market forecast, by regions, by Type and by End User, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Organs-on-Chips.
Chapter 13, to describe Human Organs-on-Chips research findings and conclusion.
授權報價
| Single User License | $3,480 USD |
| Multi User License | $5,220 USD |
| Corporate Users License | $6,960 USD |
目錄 Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Human Organs-on-Chips by Type
1.3.1 Overview: Global Human Organs-on-Chips Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Human Organs-on-Chips Consumption Value Market Share by Type in 2025
1.3.3 Brain-on-a-chip
1.3.4 Liver-on-a-chip
1.3.5 Kidney-on-a-chip
1.3.6 Lung-on-a-chip
1.3.7 Heart-on-a-chip
1.3.8 Intestine-on-a-chip
1.3.9 Vessel-on-a-chip
1.3.10 Other Organs
1.4 Classification of Human Organs-on-Chips by Technology
1.4.1 Overview: Global Human Organs-on-Chips Market Size by Technology: 2021 Versus 2025 Versus 2032
1.4.2 Global Human Organs-on-Chips Consumption Value Market Share by Technology in 2025
1.4.3 Cell Monolayer Chip
1.4.4 Scaffold or Hydrogel 3D Chip
1.4.5 Spheroid Chip
1.4.6 Other
1.5 Classification of Human Organs-on-Chips by Integration Level
1.5.1 Overview: Global Human Organs-on-Chips Market Size by Integration Level: 2021 Versus 2025 Versus 2032
1.5.2 Global Human Organs-on-Chips Consumption Value Market Share by Integration Level in 2025
1.5.3 Single-Organ Chip
1.5.4 Multi-Tissue Organ Chip
1.5.5 Others
1.6 Global Human Organs-on-Chips Market by End User
1.6.1 Overview: Global Human Organs-on-Chips Market Size by End User: 2021 Versus 2025 Versus 2032
1.6.2 Pharmaceutical & Biotechnology Companies
1.6.3 Academic & Research Institutes
1.6.4 Cosmetics Industry
1.6.5 Others
1.7 Global Human Organs-on-Chips Market Size & Forecast
1.8 Global Human Organs-on-Chips Market Size and Forecast by Region
1.8.1 Global Human Organs-on-Chips Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Human Organs-on-Chips Market Size by Region, (2021-2032)
1.8.3 North America Human Organs-on-Chips Market Size and Prospect (2021-2032)
1.8.4 Europe Human Organs-on-Chips Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Human Organs-on-Chips Market Size and Prospect (2021-2032)
1.8.6 South America Human Organs-on-Chips Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Human Organs-on-Chips Market Size and Prospect (2021-2032)
2 Company Profiles
2.1 Emulate
2.1.1 Emulate Details
2.1.2 Emulate Major Business
2.1.3 Emulate Human Organs-on-Chips Product and Solutions
2.1.4 Emulate Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Emulate Recent Developments and Future Plans
2.2 Mimetas
2.2.1 Mimetas Details
2.2.2 Mimetas Major Business
2.2.3 Mimetas Human Organs-on-Chips Product and Solutions
2.2.4 Mimetas Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Mimetas Recent Developments and Future Plans
2.3 TissUse
2.3.1 TissUse Details
2.3.2 TissUse Major Business
2.3.3 TissUse Human Organs-on-Chips Product and Solutions
2.3.4 TissUse Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 TissUse Recent Developments and Future Plans
2.4 Valo Health
2.4.1 Valo Health Details
2.4.2 Valo Health Major Business
2.4.3 Valo Health Human Organs-on-Chips Product and Solutions
2.4.4 Valo Health Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Valo Health Recent Developments and Future Plans
2.5 CN Bio Innovations
2.5.1 CN Bio Innovations Details
2.5.2 CN Bio Innovations Major Business
2.5.3 CN Bio Innovations Human Organs-on-Chips Product and Solutions
2.5.4 CN Bio Innovations Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 CN Bio Innovations Recent Developments and Future Plans
2.6 Hesperos
2.6.1 Hesperos Details
2.6.2 Hesperos Major Business
2.6.3 Hesperos Human Organs-on-Chips Product and Solutions
2.6.4 Hesperos Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Hesperos Recent Developments and Future Plans
2.7 Draper Laboratory
2.7.1 Draper Laboratory Details
2.7.2 Draper Laboratory Major Business
2.7.3 Draper Laboratory Human Organs-on-Chips Product and Solutions
2.7.4 Draper Laboratory Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Draper Laboratory Recent Developments and Future Plans
2.8 Nortis
2.8.1 Nortis Details
2.8.2 Nortis Major Business
2.8.3 Nortis Human Organs-on-Chips Product and Solutions
2.8.4 Nortis Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Nortis Recent Developments and Future Plans
2.9 Micronit Microtechnologies B.V.
2.9.1 Micronit Microtechnologies B.V. Details
2.9.2 Micronit Microtechnologies B.V. Major Business
2.9.3 Micronit Microtechnologies B.V. Human Organs-on-Chips Product and Solutions
2.9.4 Micronit Microtechnologies B.V. Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Micronit Microtechnologies B.V. Recent Developments and Future Plans
2.10 Kirkstall
2.10.1 Kirkstall Details
2.10.2 Kirkstall Major Business
2.10.3 Kirkstall Human Organs-on-Chips Product and Solutions
2.10.4 Kirkstall Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Kirkstall Recent Developments and Future Plans
2.11 Cherry Biotech SAS
2.11.1 Cherry Biotech SAS Details
2.11.2 Cherry Biotech SAS Major Business
2.11.3 Cherry Biotech SAS Human Organs-on-Chips Product and Solutions
2.11.4 Cherry Biotech SAS Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Cherry Biotech SAS Recent Developments and Future Plans
2.12 Else Kooi Laboratory
2.12.1 Else Kooi Laboratory Details
2.12.2 Else Kooi Laboratory Major Business
2.12.3 Else Kooi Laboratory Human Organs-on-Chips Product and Solutions
2.12.4 Else Kooi Laboratory Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Else Kooi Laboratory Recent Developments and Future Plans
2.13 Altis Biosystems
2.13.1 Altis Biosystems Details
2.13.2 Altis Biosystems Major Business
2.13.3 Altis Biosystems Human Organs-on-Chips Product and Solutions
2.13.4 Altis Biosystems Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Altis Biosystems Recent Developments and Future Plans
2.14 Bi/ond
2.14.1 Bi/ond Details
2.14.2 Bi/ond Major Business
2.14.3 Bi/ond Human Organs-on-Chips Product and Solutions
2.14.4 Bi/ond Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Bi/ond Recent Developments and Future Plans
2.15 Netri
2.15.1 Netri Details
2.15.2 Netri Major Business
2.15.3 Netri Human Organs-on-Chips Product and Solutions
2.15.4 Netri Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Netri Recent Developments and Future Plans
2.16 Xona Microfluidics
2.16.1 Xona Microfluidics Details
2.16.2 Xona Microfluidics Major Business
2.16.3 Xona Microfluidics Human Organs-on-Chips Product and Solutions
2.16.4 Xona Microfluidics Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Xona Microfluidics Recent Developments and Future Plans
2.17 SynVivo
2.17.1 SynVivo Details
2.17.2 SynVivo Major Business
2.17.3 SynVivo Human Organs-on-Chips Product and Solutions
2.17.4 SynVivo Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 SynVivo Recent Developments and Future Plans
2.18 Beijing Daxiang Biotech
2.18.1 Beijing Daxiang Biotech Details
2.18.2 Beijing Daxiang Biotech Major Business
2.18.3 Beijing Daxiang Biotech Human Organs-on-Chips Product and Solutions
2.18.4 Beijing Daxiang Biotech Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Beijing Daxiang Biotech Recent Developments and Future Plans
2.19 AVATARGET
2.19.1 AVATARGET Details
2.19.2 AVATARGET Major Business
2.19.3 AVATARGET Human Organs-on-Chips Product and Solutions
2.19.4 AVATARGET Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 AVATARGET Recent Developments and Future Plans
2.20 Suzhou Jiyan Biopharmaceutical
2.20.1 Suzhou Jiyan Biopharmaceutical Details
2.20.2 Suzhou Jiyan Biopharmaceutical Major Business
2.20.3 Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Product and Solutions
2.20.4 Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Suzhou Jiyan Biopharmaceutical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Human Organs-on-Chips Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Human Organs-on-Chips by Company Revenue
3.2.2 Top 3 Human Organs-on-Chips Players Market Share in 2025
3.2.3 Top 6 Human Organs-on-Chips Players Market Share in 2025
3.3 Human Organs-on-Chips Market: Overall Company Footprint Analysis
3.3.1 Human Organs-on-Chips Market: Region Footprint
3.3.2 Human Organs-on-Chips Market: Company Product Type Footprint
3.3.3 Human Organs-on-Chips Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Human Organs-on-Chips Consumption Value and Market Share by Type (2021-2026)
4.2 Global Human Organs-on-Chips Market Forecast by Type (2027-2032)
5 Market Size Segment by End User
5.1 Global Human Organs-on-Chips Consumption Value Market Share by End User (2021-2026)
5.2 Global Human Organs-on-Chips Market Forecast by End User (2027-2032)
6 North America
6.1 North America Human Organs-on-Chips Consumption Value by Type (2021-2032)
6.2 North America Human Organs-on-Chips Market Size by End User (2021-2032)
6.3 North America Human Organs-on-Chips Market Size by Country
6.3.1 North America Human Organs-on-Chips Consumption Value by Country (2021-2032)
6.3.2 United States Human Organs-on-Chips Market Size and Forecast (2021-2032)
6.3.3 Canada Human Organs-on-Chips Market Size and Forecast (2021-2032)
6.3.4 Mexico Human Organs-on-Chips Market Size and Forecast (2021-2032)
7 Europe
7.1 Europe Human Organs-on-Chips Consumption Value by Type (2021-2032)
7.2 Europe Human Organs-on-Chips Consumption Value by End User (2021-2032)
7.3 Europe Human Organs-on-Chips Market Size by Country
7.3.1 Europe Human Organs-on-Chips Consumption Value by Country (2021-2032)
7.3.2 Germany Human Organs-on-Chips Market Size and Forecast (2021-2032)
7.3.3 France Human Organs-on-Chips Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Human Organs-on-Chips Market Size and Forecast (2021-2032)
7.3.5 Russia Human Organs-on-Chips Market Size and Forecast (2021-2032)
7.3.6 Italy Human Organs-on-Chips Market Size and Forecast (2021-2032)
8 Asia-Pacific
8.1 Asia-Pacific Human Organs-on-Chips Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Human Organs-on-Chips Consumption Value by End User (2021-2032)
8.3 Asia-Pacific Human Organs-on-Chips Market Size by Region
8.3.1 Asia-Pacific Human Organs-on-Chips Consumption Value by Region (2021-2032)
8.3.2 China Human Organs-on-Chips Market Size and Forecast (2021-2032)
8.3.3 Japan Human Organs-on-Chips Market Size and Forecast (2021-2032)
8.3.4 South Korea Human Organs-on-Chips Market Size and Forecast (2021-2032)
8.3.5 India Human Organs-on-Chips Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Human Organs-on-Chips Market Size and Forecast (2021-2032)
8.3.7 Australia Human Organs-on-Chips Market Size and Forecast (2021-2032)
9 South America
9.1 South America Human Organs-on-Chips Consumption Value by Type (2021-2032)
9.2 South America Human Organs-on-Chips Consumption Value by End User (2021-2032)
9.3 South America Human Organs-on-Chips Market Size by Country
9.3.1 South America Human Organs-on-Chips Consumption Value by Country (2021-2032)
9.3.2 Brazil Human Organs-on-Chips Market Size and Forecast (2021-2032)
9.3.3 Argentina Human Organs-on-Chips Market Size and Forecast (2021-2032)
10 Middle East & Africa
10.1 Middle East & Africa Human Organs-on-Chips Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Human Organs-on-Chips Consumption Value by End User (2021-2032)
10.3 Middle East & Africa Human Organs-on-Chips Market Size by Country
10.3.1 Middle East & Africa Human Organs-on-Chips Consumption Value by Country (2021-2032)
10.3.2 Turkey Human Organs-on-Chips Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Human Organs-on-Chips Market Size and Forecast (2021-2032)
10.3.4 UAE Human Organs-on-Chips Market Size and Forecast (2021-2032)
11 Market Dynamics
11.1 Human Organs-on-Chips Market Drivers
11.2 Human Organs-on-Chips Market Restraints
11.3 Human Organs-on-Chips Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Human Organs-on-Chips Industry Chain
12.2 Human Organs-on-Chips Upstream Analysis
12.3 Human Organs-on-Chips Midstream Analysis
12.4 Human Organs-on-Chips Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Global Human Organs-on-Chips Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Human Organs-on-Chips Consumption Value by Technology, (USD Million), 2021 & 2025 & 2032
Table 3. Global Human Organs-on-Chips Consumption Value by Integration Level, (USD Million), 2021 & 2025 & 2032
Table 4. Global Human Organs-on-Chips Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Table 5. Global Human Organs-on-Chips Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Human Organs-on-Chips Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Emulate Company Information, Head Office, and Major Competitors
Table 8. Emulate Major Business
Table 9. Emulate Human Organs-on-Chips Product and Solutions
Table 10. Emulate Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Emulate Recent Developments and Future Plans
Table 12. Mimetas Company Information, Head Office, and Major Competitors
Table 13. Mimetas Major Business
Table 14. Mimetas Human Organs-on-Chips Product and Solutions
Table 15. Mimetas Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Mimetas Recent Developments and Future Plans
Table 17. TissUse Company Information, Head Office, and Major Competitors
Table 18. TissUse Major Business
Table 19. TissUse Human Organs-on-Chips Product and Solutions
Table 20. TissUse Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Valo Health Company Information, Head Office, and Major Competitors
Table 22. Valo Health Major Business
Table 23. Valo Health Human Organs-on-Chips Product and Solutions
Table 24. Valo Health Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Valo Health Recent Developments and Future Plans
Table 26. CN Bio Innovations Company Information, Head Office, and Major Competitors
Table 27. CN Bio Innovations Major Business
Table 28. CN Bio Innovations Human Organs-on-Chips Product and Solutions
Table 29. CN Bio Innovations Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. CN Bio Innovations Recent Developments and Future Plans
Table 31. Hesperos Company Information, Head Office, and Major Competitors
Table 32. Hesperos Major Business
Table 33. Hesperos Human Organs-on-Chips Product and Solutions
Table 34. Hesperos Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Hesperos Recent Developments and Future Plans
Table 36. Draper Laboratory Company Information, Head Office, and Major Competitors
Table 37. Draper Laboratory Major Business
Table 38. Draper Laboratory Human Organs-on-Chips Product and Solutions
Table 39. Draper Laboratory Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Draper Laboratory Recent Developments and Future Plans
Table 41. Nortis Company Information, Head Office, and Major Competitors
Table 42. Nortis Major Business
Table 43. Nortis Human Organs-on-Chips Product and Solutions
Table 44. Nortis Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Nortis Recent Developments and Future Plans
Table 46. Micronit Microtechnologies B.V. Company Information, Head Office, and Major Competitors
Table 47. Micronit Microtechnologies B.V. Major Business
Table 48. Micronit Microtechnologies B.V. Human Organs-on-Chips Product and Solutions
Table 49. Micronit Microtechnologies B.V. Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Micronit Microtechnologies B.V. Recent Developments and Future Plans
Table 51. Kirkstall Company Information, Head Office, and Major Competitors
Table 52. Kirkstall Major Business
Table 53. Kirkstall Human Organs-on-Chips Product and Solutions
Table 54. Kirkstall Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Kirkstall Recent Developments and Future Plans
Table 56. Cherry Biotech SAS Company Information, Head Office, and Major Competitors
Table 57. Cherry Biotech SAS Major Business
Table 58. Cherry Biotech SAS Human Organs-on-Chips Product and Solutions
Table 59. Cherry Biotech SAS Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Cherry Biotech SAS Recent Developments and Future Plans
Table 61. Else Kooi Laboratory Company Information, Head Office, and Major Competitors
Table 62. Else Kooi Laboratory Major Business
Table 63. Else Kooi Laboratory Human Organs-on-Chips Product and Solutions
Table 64. Else Kooi Laboratory Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Else Kooi Laboratory Recent Developments and Future Plans
Table 66. Altis Biosystems Company Information, Head Office, and Major Competitors
Table 67. Altis Biosystems Major Business
Table 68. Altis Biosystems Human Organs-on-Chips Product and Solutions
Table 69. Altis Biosystems Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Altis Biosystems Recent Developments and Future Plans
Table 71. Bi/ond Company Information, Head Office, and Major Competitors
Table 72. Bi/ond Major Business
Table 73. Bi/ond Human Organs-on-Chips Product and Solutions
Table 74. Bi/ond Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Bi/ond Recent Developments and Future Plans
Table 76. Netri Company Information, Head Office, and Major Competitors
Table 77. Netri Major Business
Table 78. Netri Human Organs-on-Chips Product and Solutions
Table 79. Netri Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Netri Recent Developments and Future Plans
Table 81. Xona Microfluidics Company Information, Head Office, and Major Competitors
Table 82. Xona Microfluidics Major Business
Table 83. Xona Microfluidics Human Organs-on-Chips Product and Solutions
Table 84. Xona Microfluidics Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Xona Microfluidics Recent Developments and Future Plans
Table 86. SynVivo Company Information, Head Office, and Major Competitors
Table 87. SynVivo Major Business
Table 88. SynVivo Human Organs-on-Chips Product and Solutions
Table 89. SynVivo Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. SynVivo Recent Developments and Future Plans
Table 91. Beijing Daxiang Biotech Company Information, Head Office, and Major Competitors
Table 92. Beijing Daxiang Biotech Major Business
Table 93. Beijing Daxiang Biotech Human Organs-on-Chips Product and Solutions
Table 94. Beijing Daxiang Biotech Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Beijing Daxiang Biotech Recent Developments and Future Plans
Table 96. AVATARGET Company Information, Head Office, and Major Competitors
Table 97. AVATARGET Major Business
Table 98. AVATARGET Human Organs-on-Chips Product and Solutions
Table 99. AVATARGET Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. AVATARGET Recent Developments and Future Plans
Table 101. Suzhou Jiyan Biopharmaceutical Company Information, Head Office, and Major Competitors
Table 102. Suzhou Jiyan Biopharmaceutical Major Business
Table 103. Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Product and Solutions
Table 104. Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Suzhou Jiyan Biopharmaceutical Recent Developments and Future Plans
Table 106. Global Human Organs-on-Chips Revenue (USD Million) by Players (2021-2026)
Table 107. Global Human Organs-on-Chips Revenue Share by Players (2021-2026)
Table 108. Breakdown of Human Organs-on-Chips by Company Type (Tier 1, Tier 2, and Tier 3)
Table 109. Market Position of Players in Human Organs-on-Chips, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 110. Head Office of Key Human Organs-on-Chips Players
Table 111. Human Organs-on-Chips Market: Company Product Type Footprint
Table 112. Human Organs-on-Chips Market: Company Product Application Footprint
Table 113. Human Organs-on-Chips New Market Entrants and Barriers to Market Entry
Table 114. Human Organs-on-Chips Mergers, Acquisition, Agreements, and Collaborations
Table 115. Global Human Organs-on-Chips Consumption Value (USD Million) by Type (2021-2026)
Table 116. Global Human Organs-on-Chips Consumption Value Share by Type (2021-2026)
Table 117. Global Human Organs-on-Chips Consumption Value Forecast by Type (2027-2032)
Table 118. Global Human Organs-on-Chips Consumption Value by End User (2021-2026)
Table 119. Global Human Organs-on-Chips Consumption Value Forecast by End User (2027-2032)
Table 120. North America Human Organs-on-Chips Consumption Value by Type (2021-2026) & (USD Million)
Table 121. North America Human Organs-on-Chips Consumption Value by Type (2027-2032) & (USD Million)
Table 122. North America Human Organs-on-Chips Consumption Value by End User (2021-2026) & (USD Million)
Table 123. North America Human Organs-on-Chips Consumption Value by End User (2027-2032) & (USD Million)
Table 124. North America Human Organs-on-Chips Consumption Value by Country (2021-2026) & (USD Million)
Table 125. North America Human Organs-on-Chips Consumption Value by Country (2027-2032) & (USD Million)
Table 126. Europe Human Organs-on-Chips Consumption Value by Type (2021-2026) & (USD Million)
Table 127. Europe Human Organs-on-Chips Consumption Value by Type (2027-2032) & (USD Million)
Table 128. Europe Human Organs-on-Chips Consumption Value by End User (2021-2026) & (USD Million)
Table 129. Europe Human Organs-on-Chips Consumption Value by End User (2027-2032) & (USD Million)
Table 130. Europe Human Organs-on-Chips Consumption Value by Country (2021-2026) & (USD Million)
Table 131. Europe Human Organs-on-Chips Consumption Value by Country (2027-2032) & (USD Million)
Table 132. Asia-Pacific Human Organs-on-Chips Consumption Value by Type (2021-2026) & (USD Million)
Table 133. Asia-Pacific Human Organs-on-Chips Consumption Value by Type (2027-2032) & (USD Million)
Table 134. Asia-Pacific Human Organs-on-Chips Consumption Value by End User (2021-2026) & (USD Million)
Table 135. Asia-Pacific Human Organs-on-Chips Consumption Value by End User (2027-2032) & (USD Million)
Table 136. Asia-Pacific Human Organs-on-Chips Consumption Value by Region (2021-2026) & (USD Million)
Table 137. Asia-Pacific Human Organs-on-Chips Consumption Value by Region (2027-2032) & (USD Million)
Table 138. South America Human Organs-on-Chips Consumption Value by Type (2021-2026) & (USD Million)
Table 139. South America Human Organs-on-Chips Consumption Value by Type (2027-2032) & (USD Million)
Table 140. South America Human Organs-on-Chips Consumption Value by End User (2021-2026) & (USD Million)
Table 141. South America Human Organs-on-Chips Consumption Value by End User (2027-2032) & (USD Million)
Table 142. South America Human Organs-on-Chips Consumption Value by Country (2021-2026) & (USD Million)
Table 143. South America Human Organs-on-Chips Consumption Value by Country (2027-2032) & (USD Million)
Table 144. Middle East & Africa Human Organs-on-Chips Consumption Value by Type (2021-2026) & (USD Million)
Table 145. Middle East & Africa Human Organs-on-Chips Consumption Value by Type (2027-2032) & (USD Million)
Table 146. Middle East & Africa Human Organs-on-Chips Consumption Value by End User (2021-2026) & (USD Million)
Table 147. Middle East & Africa Human Organs-on-Chips Consumption Value by End User (2027-2032) & (USD Million)
Table 148. Middle East & Africa Human Organs-on-Chips Consumption Value by Country (2021-2026) & (USD Million)
Table 149. Middle East & Africa Human Organs-on-Chips Consumption Value by Country (2027-2032) & (USD Million)
Table 150. Global Key Players of Human Organs-on-Chips Upstream (Raw Materials)
Table 151. Global Human Organs-on-Chips Typical Customers
List of Figures
Figure 1. Human Organs-on-Chips Picture
Figure 2. Global Human Organs-on-Chips Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Human Organs-on-Chips Consumption Value Market Share by Type in 2025
Figure 4. Brain-on-a-chip
Figure 5. Liver-on-a-chip
Figure 6. Kidney-on-a-chip
Figure 7. Lung-on-a-chip
Figure 8. Heart-on-a-chip
Figure 9. Intestine-on-a-chip
Figure 10. Vessel-on-a-chip
Figure 11. Other Organs
Figure 12. Global Human Organs-on-Chips Consumption Value by Technology, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Human Organs-on-Chips Consumption Value Market Share by Technology in 2025
Figure 14. Cell Monolayer Chip
Figure 15. Scaffold or Hydrogel 3D Chip
Figure 16. Spheroid Chip
Figure 17. Other
Figure 18. Global Human Organs-on-Chips Consumption Value by Integration Level, (USD Million), 2021 & 2025 & 2032
Figure 19. Global Human Organs-on-Chips Consumption Value Market Share by Integration Level in 2025
Figure 20. Single-Organ Chip
Figure 21. Multi-Tissue Organ Chip
Figure 22. Others
Figure 23. Global Human Organs-on-Chips Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Figure 24. Human Organs-on-Chips Consumption Value Market Share by End User in 2025
Figure 25. Pharmaceutical & Biotechnology Companies Picture
Figure 26. Academic & Research Institutes Picture
Figure 27. Cosmetics Industry Picture
Figure 28. Others Picture
Figure 29. Global Human Organs-on-Chips Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 30. Global Human Organs-on-Chips Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 31. Global Market Human Organs-on-Chips Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 32. Global Human Organs-on-Chips Consumption Value Market Share by Region (2021-2032)
Figure 33. Global Human Organs-on-Chips Consumption Value Market Share by Region in 2025
Figure 34. North America Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 35. Europe Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 36. Asia-Pacific Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 37. South America Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 38. Middle East & Africa Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 39. Company Three Recent Developments and Future Plans
Figure 40. Global Human Organs-on-Chips Revenue Share by Players in 2025
Figure 41. Human Organs-on-Chips Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 42. Market Share of Human Organs-on-Chips by Player Revenue in 2025
Figure 43. Top 3 Human Organs-on-Chips Players Market Share in 2025
Figure 44. Top 6 Human Organs-on-Chips Players Market Share in 2025
Figure 45. Global Human Organs-on-Chips Consumption Value Share by Type (2021-2026)
Figure 46. Global Human Organs-on-Chips Market Share Forecast by Type (2027-2032)
Figure 47. Global Human Organs-on-Chips Consumption Value Share by End User (2021-2026)
Figure 48. Global Human Organs-on-Chips Market Share Forecast by End User (2027-2032)
Figure 49. North America Human Organs-on-Chips Consumption Value Market Share by Type (2021-2032)
Figure 50. North America Human Organs-on-Chips Consumption Value Market Share by End User (2021-2032)
Figure 51. North America Human Organs-on-Chips Consumption Value Market Share by Country (2021-2032)
Figure 52. United States Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 53. Canada Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 54. Mexico Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 55. Europe Human Organs-on-Chips Consumption Value Market Share by Type (2021-2032)
Figure 56. Europe Human Organs-on-Chips Consumption Value Market Share by End User (2021-2032)
Figure 57. Europe Human Organs-on-Chips Consumption Value Market Share by Country (2021-2032)
Figure 58. Germany Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 59. France Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 60. United Kingdom Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 61. Russia Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 62. Italy Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 63. Asia-Pacific Human Organs-on-Chips Consumption Value Market Share by Type (2021-2032)
Figure 64. Asia-Pacific Human Organs-on-Chips Consumption Value Market Share by End User (2021-2032)
Figure 65. Asia-Pacific Human Organs-on-Chips Consumption Value Market Share by Region (2021-2032)
Figure 66. China Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 67. Japan Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 68. South Korea Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 69. India Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 70. Southeast Asia Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 71. Australia Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 72. South America Human Organs-on-Chips Consumption Value Market Share by Type (2021-2032)
Figure 73. South America Human Organs-on-Chips Consumption Value Market Share by End User (2021-2032)
Figure 74. South America Human Organs-on-Chips Consumption Value Market Share by Country (2021-2032)
Figure 75. Brazil Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 76. Argentina Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 77. Middle East & Africa Human Organs-on-Chips Consumption Value Market Share by Type (2021-2032)
Figure 78. Middle East & Africa Human Organs-on-Chips Consumption Value Market Share by End User (2021-2032)
Figure 79. Middle East & Africa Human Organs-on-Chips Consumption Value Market Share by Country (2021-2032)
Figure 80. Turkey Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 81. Saudi Arabia Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 82. UAE Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 83. Human Organs-on-Chips Market Drivers
Figure 84. Human Organs-on-Chips Market Restraints
Figure 85. Human Organs-on-Chips Market Trends
Figure 86. Porters Five Forces Analysis
Figure 87. Human Organs-on-Chips Industrial Chain
Figure 88. Methodology
Figure 89. Research Process and Data Source
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Global Info Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們